Apogee Therapeutics Inc. (APGE) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Apogee Therapeutics Inc.

    NASDAQ: APGE · Real-Time Price · USD
    37.87
    0.74 (1.99%)
    At close: Sep 05, 2025, 3:59 PM
    37.12
    -1.98%
    After-hours: Sep 05, 2025, 07:41 PM EDT

    Apogee Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022
    Revenue
    		 n/a n/a n/a
    Cost of Revenue
    		 189K n/a n/a
    Gross Profit
    		 -189K n/a n/a
    Operating Income
    		 -216.87M -93M -30.73M
    Interest Income
    		 34.74M 9.02M 92K
    Pretax Income
    		 -182.13M -83.98M -39.78M
    Net Income
    		 -182.15M -83.98M -39.78M
    Selling & General & Admin
    		 49.01M 24.58M 2.94M
    Research & Development
    		 167.87M 68.42M 27.79M
    Other Expenses
    		 n/a n/a n/a
    Operating Expenses
    		 216.87M 93M 30.73M
    Interest Expense
    		 n/a n/a 9.15M
    Selling & Marketing Expenses
    		 n/a n/a n/a
    Cost & Expenses
    		 216.87M 93M 30.73M
    Income Tax Expense
    		 -18K n/a -33.52K
    Shares Outstanding (Basic)
    		 55.19M 50.66M 50.67M
    Shares Outstanding (Diluted)
    		 55.19M 50.66M 50.67M
    EPS (Basic)
    		 -3.3 -1.66 -0.79
    EPS (Diluted)
    		 -3.3 -1.66 -0.79
    EBITDA
    		 -216.87M -83.98M -39.78M
    EBIT
    		 -182.13M -83.98M -39.78M
    Depreciation & Amortization
    		 189K 9.02M n/a

    Add to Watchlist